Latest News and Press Releases

Ipamorelin vs Sermorelin 2026 analysis compares growth hormone peptide mechanisms, regulatory status, and prescription telehealth access pathways.

2026 independent analysis examines Rejuvacare Ozempatch ingredient disclosures, GLP-1 terminology, and herbal patch regulatory classification.

Best titanium cutting board for 2026: Consumer analysis examines TIBO as microplastic research and hygiene priorities reshape kitchen decisions.

GLP-1 Booster from Health Journey examined: Akkermansia, Clostridium butyricum, gut microbiome probiotic research and metabolic science for 2026.

Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026.

NAD+ research examines cellular aging as telehealth expands peptide therapy access — RenuviaRX platform model, pricing, and oversight revealed.

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase...

Consumer analysis explores anti-snoring mouthpiece vs nose strip formats, examining SleepZee as one example within broader sleep research.

北卡罗来纳州罗利, Jan. 10, 2026 (GLOBE NEWSWIRE) --  Attindas Hygiene Partners 的增长战略通过今日收购 Società Italiana Lavorazione Cellulosa (SILC S.p.A.) 迈出了重要一步。Attindas 已与 SILC 签署股份收购协议，收购这家拥有 53 年历史的家族企业的全部股份。 ...

High 5 Casino expands PayPal payment support, highlighting security, transaction access, and mobile compatibility trends shaping online gaming.